Antengene (FRA:722) ROE % Adjusted to Book Value : -100.52% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Antengene ROE % Adjusted to Book Value?

Antengene's ROE % for the quarter that ended in Jun. 2024 was -31.16%. Antengene's PB Ratio for the quarter that ended in Jun. 2024 was 0.31. Antengene's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -100.52%.

Antengene ROE % Adjusted to Book Value Historical Data

The historical data trend for Antengene's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene ROE % Adjusted to Book Value Chart

Antengene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-12.75

-18.26

-46.29

-92.40

Antengene Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial								-28.80	-51.50	-65.13	-100.52	-95.54

Competitive Comparison of Antengene's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Antengene's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antengene's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Antengene's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Antengene's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Antengene ROE % Adjusted to Book Value Calculation

Antengene's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-39.35%	/	0.85
	=	-46.29%

Antengene's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-31.16%	/	0.31
	=	-100.52%

Antengene ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Antengene's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Antengene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (FRA:722) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

06996:Hong Kong 722:Germany

Address

1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN

Website

https://www.antengene.com

Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Antengene Headlines

No Headlines